Cargando…
Integrative Genome Comparison of Primary and Metastatic Melanomas
A cardinal feature of malignant melanoma is its metastatic propensity. An incomplete view of the genetic events driving metastatic progression has been a major barrier to rational development of effective therapeutics and prognostic diagnostics for melanoma patients. In this study, we conducted glob...
Autores principales: | Kabbarah, Omar, Nogueira, Cristina, Feng, Bin, Nazarian, Rosalynn M., Bosenberg, Marcus, Wu, Min, Scott, Kenneth L., Kwong, Lawrence N., Xiao, Yonghong, Cordon-Cardo, Carlos, Granter, Scott R., Ramaswamy, Sridhar, Golub, Todd, Duncan, Lyn M., Wagner, Stephan N., Brennan, Cameron, Chin, Lynda |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875381/ https://www.ncbi.nlm.nih.gov/pubmed/20520718 http://dx.doi.org/10.1371/journal.pone.0010770 |
Ejemplares similares
-
Cooperative interactions of PTEN deficiency and RAS activation in melanoma metastasis
por: Nogueira, Cristina, et al.
Publicado: (2010) -
MGH Whole Slide Imaging Teleconsultation Practice in Dermatopathology
por: Jones, Nicholas C., et al.
Publicado: (2014) -
Dual Suppression of the Cyclin-Dependent Kinase Inhibitors CDKN2C and CDKN1A in Human Melanoma
por: Jalili, Ahmad, et al.
Publicado: (2012) -
Metastatic melanoma with spontaneous complete regression of a thick primary lesion
por: Khosravi, Hasan, et al.
Publicado: (2016) -
A phase I trial of panobinostat (LBH589) in patients with metastatic melanoma
por: Ibrahim, Nageatte, et al.
Publicado: (2016)